2015
Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis A Prospective Study From the International Collaboration on Endocarditis
CHU, Vivian H., Lawrence P. PARK, Eugene ATHAN, Francois DELAHAYE, Tomáš FREIBERGER et. al.Základní údaje
Originální název
Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis A Prospective Study From the International Collaboration on Endocarditis
Autoři
CHU, Vivian H. (840 Spojené státy), Lawrence P. PARK (840 Spojené státy), Eugene ATHAN (36 Austrálie), Francois DELAHAYE (250 Francie), Tomáš FREIBERGER (203 Česká republika, garant, domácí), Cristiane LAMAS (76 Brazílie), Jose M. MIRO (724 Španělsko), Daniel W. MUDRICK (840 Spojené státy), Jacob STRAHILEVITZ (376 Izrael), Christophe TRIBOUILLOY (250 Francie), Emanuele DURANTE-MANGONI (380 Itálie), Juan M. PERICAS (724 Španělsko), Nuria FERNANDEZ-HIDALGO (724 Španělsko), Francisco NACINOVICH (32 Argentina), Hussein RIZK (818 Egypt), Vladimir KRAJINOVIC (191 Chorvatsko), Efthymia GIANNITSIOTI (300 Řecko), John P. HURLEY (372 Irsko), Margaret M. HANNAN (372 Irsko) a Andrew WANG (840 Spojené státy)
Vydání
Circulation, Philadelphia, Lippincott Williams Wilkins, 2015, 0009-7322
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 17.202
Kód RIV
RIV/00216224:14740/15:00084486
Organizační jednotka
Středoevropský technologický institut
UT WoS
000347791000009
Klíčová slova anglicky
endocarditis; infection; mortality; surgery; valve
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 1. 4. 2016 13:47, Mgr. Eva Špillingová
Anotace
V originále
Background-Use of surgery for the treatment of infective endocarditis (IE) as related to surgical indications and operative risk for mortality has not been well defined. Methods and Results-The International Collaboration on Endocarditis-PLUS (ICE-PLUS) is a prospective cohort of consecutively enrolled patients with definite IE from 29 centers in 16 countries. We included patients from ICE-PLUS with definite left-sided, non-cardiac device-related IE who were enrolled between September 1, 2008, and December 31, 2012. A total of 1296 patients with left-sided IE were included. Surgical treatment was performed in 57% of the overall cohort and in 76% of patients with a surgical indication. Reasons for nonsurgical treatment included poor prognosis (33.7%), hemodynamic instability (19.8%), death before surgery (23.3%), stroke (22.7%), and sepsis (21%). Among patients with a surgical indication, surgical treatment was independently associated with the presence of severe aortic regurgitation, abscess, embolization before surgical treatment, and transfer from an outside hospital. Variables associated with nonsurgical treatment were a history of moderate/severe liver disease, stroke before surgical decision, and Staphyloccus aureus etiology. The integration of surgical indication, Society of Thoracic Surgeons IE score, and use of surgery was associated with 6-month survival in IE. Conclusions-Surgical decision making in IE is largely consistent with established guidelines, although nearly one quarter of patients with surgical indications do not undergo surgery. Operative risk assessment by Society of Thoracic Surgeons IE score provides prognostic information for survival beyond the operative period. S aureus IE was significantly associated with nonsurgical management.